Fuad El-hibri - Net Worth and Insider Trading
Fuad El-hibri Net Worth
The estimated net worth of Fuad El-hibri is at least $10 Million dollars as of 2024-04-25. Fuad El-hibri is the Chairman, 10% Owner of Emergent BioSolutions Inc and owns about 4,788,606 shares of Emergent BioSolutions Inc (EBS) stock worth over $10 Million. Fuad El-hibri is also the Director of Aptevo Therapeutics Inc and owns about 6,589 shares of Aptevo Therapeutics Inc (APVO) stock worth over $4,498. Details can be seen in Fuad El-hibri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fuad El-hibri has not made any transactions after 2020-11-10 and currently still holds the listed stock(s).
Transaction Summary of Fuad El-hibri
Fuad El-hibri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fuad El-hibri owns 2 companies in total, including Emergent BioSolutions Inc () , and Aptevo Therapeutics Inc () .
Click here to see the complete history of Fuad El-hibri’s form 4 insider trades.
Insider Ownership Summary of Fuad El-hibri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Emergent BioSolutions Inc | 2020-11-10 | director & 10 percent owner & Chairman | |
| Aptevo Therapeutics Inc | 2019-08-12 | director |
Fuad El-hibri Latest Holdings Summary
Fuad El-hibri currently owns a total of 2 stocks. Among these stocks, Fuad El-hibri owns 4,788,606 shares of Emergent BioSolutions Inc (EBS) as of November 10, 2020, with a value of $10 Million and a weighting of 99.96%. Fuad El-hibri also owns 6,589 shares of Aptevo Therapeutics Inc (APVO) as of August 12, 2019, with a value of $4,498 and a weighting of 0.04%.
Latest Holdings of Fuad El-hibri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2020-11-10 | 4,788,606 | 2.18 | 10,439,161 |
| APVO | Aptevo Therapeutics Inc | 2019-08-12 | 6,589 | 0.68 | 4,498 |
Holding Weightings of Fuad El-hibri
Fuad El-hibri Form 4 Trading Tracker
According to the SEC Form 4 filings, Fuad El-hibri has made a total of 16 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Emergent BioSolutions Inc is the sale of 39,391 shares on November 10, 2020, which brought Fuad El-hibri around $4 Million.
According to the SEC Form 4 filings, Fuad El-hibri has made a total of 10 transactions in Aptevo Therapeutics Inc (APVO) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Aptevo Therapeutics Inc is the acquisition of 162 shares on August 12, 2019, which cost Fuad El-hibri around $76,000.
Insider Trading History of Fuad El-hibri
- 1
Fuad El-hibri Trading Performance
GuruFocus tracks the stock performance after each of Fuad El-hibri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fuad El-hibri is -26.86%. GuruFocus also compares Fuad El-hibri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fuad El-hibri within 3 months outperforms 0 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fuad El-hibri's insider trading performs compared to the benchmark.
Performance of Fuad El-hibri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.5 | -26.86 | -24.65 | -34.23 | 28.3 | -30.16 |
| Relative Return to S&P 500(%) | -7.13 | -27.39 | -35.7 | -42.84 | 7.39 | -40.02 |
Fuad El-hibri Ownership Network
Ownership Network List of Fuad El-hibri
Ownership Network Relation of Fuad El-hibri
Fuad El-hibri Owned Company Details
What does Emergent BioSolutions Inc do?
Who are the key executives at Emergent BioSolutions Inc?
Fuad El-hibri is the director & 10 percent owner & Chairman of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .
Emergent BioSolutions Inc () Insider Trades Summary
Over the past 18 months, Fuad El-hibri made no insider transaction in Emergent BioSolutions Inc (). Other recent insider transactions involving Emergent BioSolutions Inc () include a net sale of 3,530 shares made by Kathryn C Zoon , and a net sale of 1,912 shares made by Ronald Richard .
In summary, during the past 3 months, insiders sold 0 shares of Emergent BioSolutions Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,442 shares of Emergent BioSolutions Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,442 shares.
Emergent BioSolutions Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Emergent BioSolutions Inc Insider Transactions
Fuad El-hibri Mailing Address
Above is the net worth, insider trading, and ownership report for Fuad El-hibri. You might contact Fuad El-hibri via mailing address: 2273 Research Blvd, Suite 400, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
